Navigation guide for teens and young adults during cancer treatment
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study helps teens and young adults (ages 15–24) who are currently receiving cancer treatment understand and prepare for potential long-term side effects. The goal is to keep you engaged in your care during and after treatment so you can catch and manage any late effects early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 24 years old
- You are currently undergoing active cancer treatment at Dana-Farber, Children's National Hospital, or Rocky Mountain Pediatric Oncology
- Your cancer diagnosis is one of these: sarcoma (osteosarcoma, Ewing sarcoma, or rhabdomyosarcoma), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), lymphoma (Hodgkin or mature B-cell), or medulloblastoma
- Your treatment includes certain chemotherapy drugs (alkylators or anthracyclines) and/or radiation therapy
- You speak and read English fluently
- Your doctor believes your cancer is treatable and gives permission for you to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a navigation program to help cancer survivors ages 21-45 get the follow-up care they need. It may be a good fit if you were diagnosed with certain cancers as a teen or young adult.
This study is designed to help adolescent and young adult cancer survivors manage symptoms and smoothly transition to post-treatment care. If you finished treatment for certain cancers within the past 1 to 5 years, you may be able to join.
This trial connects you with a trained peer (someone who has been through cancer) who provides support and guidance online. It's for young adults who finished treatment for certain cancers in the past year.
This study looks at how “early aging” changes show up during treatment in young adults with cancer. It may help doctors better understand health effects during curative therapy and improve care for people your age.
This study tests a program that helps caregivers of teens and young adults (AYAs) with cancer find and access the support they need. If you are the parent or financial partner of an AYA who was diagnosed in the last 3 months to just finishing treatment, this trial might offer helpful resources.
This study helps young adults who survived childhood cancer move from pediatric (children's) cancer clinics to regular adult healthcare. A patient navigator—someone trained to guide you—will help you understand your cancer history, connect with an adult doctor, and manage your health independently.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.